Attenuation of cisplatin nephrotoxicity by inhibition of soluble epoxide hydrolase

Cell Biology and Toxicology

Volumn 25, Issue 3, 2009, Pages 217-225

  Parrish, Alan R ^a   Chen, Gang ^a   Burghardt, Robert C ^b   Watanabe, Takaho ^c,d   Morisseau, Christophe ^d   Hammock, Bruce D ^d  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c HATANO RESEARCH INSTITUTE   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cisplatin; Nephrotoxicity; Soluble epoxide hydrolase

Indexed keywords

12 (3 ADAMANTAN 1 YLUREIDO)DODECANOIC ACID N BUTYL ESTER; CISPLATIN; ENZYME INHIBITOR; EPOXIDE HYDROLASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; C3H MOUSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME INHIBITION; HISTOPATHOLOGY; KIDNEY; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL;

ADAMANTANE; ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD UREA NITROGEN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CISPLATIN; DRUG ANTAGONISM; ENZYME INHIBITORS; EPOXIDE HYDROLASES; INJECTIONS, SUBCUTANEOUS; KIDNEY; KIDNEY DISEASES; LAURIC ACIDS; MALE; MICE; MICE, INBRED C3H; MICROSOMES, LIVER; RATS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

MUS;

EID: 67349209538     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10565-008-9071-0     Document Type: Article

References (50)

1. I Arany RL Safirstein 2003 Cisplatin nephrotoxicity Semin Nephrol. 23 460 4 (Pubitemid 37176691)
2. I Arany J Herbert Z Herbert RL Safirstein 2008 Restoration of CREB function ameliorates cisplatin nephrotoxicity in renal tubular cells Am J Physiol Renal Physiol 294 F577 F581 (Pubitemid 350273637)
3. R Baliga N Ueda PD Walker SV Shah 1999 Oxidant mechanisms in toxic acute renal failure Drug Metab Rev. 31 971 97
4. JV Bonventre 2007 Pathophysiology of acute kidney injury: roles of potential inhibitors of inflammation Contrib Nephrol. 156 39 46
5. YI Chirino DJ Sanchez-Gonzalez CM Martinez-Martinez C Cruz J Pedraza-Chaverri 2008 Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity Toxicology 245 18 23
6. YI Chirino J Trujillo DJ Sanchez-Gonzalez CM Martinez-Martinez C Cruz NA Bobadilla 2007 Selective iNOS inhibition reduces renal damage induced by cisplatin Toxicol Lett. 176 48 57
7. HD Francescato RS Costa FB Junior TM Coimbra 2007 Effect of JNK inhibition on cisplatin-induced renal damage Nephrol Dial Transplant. 22 2138 48 (Pubitemid 47244690)
8. I Genvresse C Lange J Schanz M Schweigert H Harder K Possinger 2001 Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study Anticancer Drugs. 12 345 9 (Pubitemid 32453440)
9. RS Go AA Adjei 1999 Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin J Clin Oncol. 17 409 22 (Pubitemid 29022420)
10. MH Hannigan P Devarajan 2003 Cisplatin nephrotoxicity: molecular mechanisms Cancer Ther. 1 47 61
11. JT Hartmann LM Fels S Knop H Stolt L Kanz C Bokemeyer 2000 A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors Invest New Drugs. 18 281 9 (Pubitemid 30599151)
12. B Hennig BD Hammock R Slim M Toborek V Saraswathi LW Robertson 2002 PCB-induced oxidative stress in endothelial cells: Modulation by nutrients Int J Hyg Environ Health. 205 95 102 (Pubitemid 34288654)
13. Q Huang RT Dunn 2nd S Jayadev Q DiSorbo RD Pack SB Farr RE Stoll KT Blanchard 2001 Assessment of cisplatin-induced nephrotoxicity by microarray technology Toxicol Sci. 63 196 207 (Pubitemid 32982793)
14. YC Hung GS Huang LW Lin MY Hong PS Se 2007 Thea sinensis melanin prevents cisplatin-induced nephrotoxicity in mice Food Chem Toxicol. 45 1123 30 (Pubitemid 46590553)
15. JD Imig 2008 Eicosanoids and renal damage in cardiometabolic syndrome Expert Opin Drug Metab Toxicol. 4 165 74
16. JD Imig X Zhao JH Capdevila C Morisseau BD Hammock 2002 Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension Hypertension. 39 690 4 (Pubitemid 34165207)
17. B Inceoglu SL Jinks KR Schmelzer T Waite IH Kim BD Hammock 2006 Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain Life Sci. 79 2311 9 (Pubitemid 44666069)
18. J Jiang D Dean RC Burghardt AR Parrish 2004 Disruption of cadherin/catenin expression, localization, and interactions during HgCl2-induced nephrotoxicity Toxicol Sci. 80 170 82 (Pubitemid 38967408)
19. SK Jo WY Cho SA Sung HK Kim NH Won 2005 MEK inhibitor, UO126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis Kidney Int. 67 458 66 (Pubitemid 40139837)
20. I-H Kim K Nishi H-J Tsai T Bradford Y Koda T Watanabe 2007 Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido) dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase Bioorg Med Chem. 15 312 23
21. PE Kintzel 2001 Anticancer drug-induced kidney disorders Drug Saf. 24 19 38
22. H Kuwana Y Terada T Kobayashi T Okado JM Penninger J Irie-Sasaki 2008 The phosphoinositide-3 kinase gamma-AKT pathway mediates renal tubular injury in cisplatin nephrotoxicity Kidney Int. 73 430 45
23. S Lee W Kim SO Moon MJ Sung DH Kim KP Kang 2006 Rosiglitazone ameliorates cisplatin-induced renal injury in mice Nephrol Dial Transplant. 21 2096 105 (Pubitemid 44295034)
24. S Li N Gokden MD Okusa R Bhatt D Portilla 2005 Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF Am J Physiol Renal Physiol. 289 F469 80 (Pubitemid 41003677)
25. Y Liu Y Zhang K Schmelzer TS Lee X Fang Y Zhu 2005 The anti-inflammatory effect of laminar flow: the role of PPARg, epoxyeicosatrienoic acids, and soluble epoxide hydrolase Proc Natl Acad Sci U S A. 102 16747 52 (Pubitemid 41688848)
26. J Lokich 2001 What is the "best" platinum: Cisplatin, carboplatin, or oxaliplatin? Cancer Invest. 19 756 60 (Pubitemid 32910996)
27. T Ludwig H Oberleithner 2004 Platinum toxicity in cultured renal epithelia Cell Physiol Biochem. 14 431 40 (Pubitemid 39179212)
28. C Morisseau MH Goodrow D Dowdy J Zheng JF Greene JR Sanborn 1999 Potent urea and carbamate inhibitors of soluble epoxide hydrolases Proc Natl Acad Sci U S A. 96 8849 54 (Pubitemid 29374671)
29. C Morisseau MH Goodrow JW Newman CE Wheelock DL Dowdy BD Hammock 2002 Structural refinement of inhibitors of urea-based soluble epoxide hydrolases Biochem Pharmacol. 63 1599 1608 (Pubitemid 34457999)
30. K Node Y Huo Y Ruan B Yang M Spiecker K Ley 1999 Antiinflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids Science. 285 1276 9 (Pubitemid 29398616)
31. M Peyrou AE Cribb 2007 Effect of endoplasmic reticulum stress preconditioning on cytotoxicity of clinically relevant nephrotoxins in renal cell lines Toxicol In Vitro. 21 878 86 (Pubitemid 46603248)
32. M Peyrou PE Hanna AE Cribb 2007 Cisplatin, gentamicin, and p-aminophenol induce markers of endoplasmic reticulum stress in the rat kidneys Toxicol Sci. 99 346 53 (Pubitemid 47250390)
33. G Ramesh WB Reeves 2002 TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity J Clin Invest. 110 835 42
34. G Ramesh B Zhang S Uematsu S Akira WB Reeves 2007 Endotoxin and cisplatin synergistically induce renal dysfunction and cytokine production in mice Am J Physiol Renal Physiol. 293 F325 32 (Pubitemid 47345033)
35. F Ries J Klastersky 1986 Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity Am J Kidney Dis. 8 368 79 (Pubitemid 17235084)
36. RJ Roman 2002 P-450 metabolites of arachidonic acid in the control of cardiovascular function Physiol Rev 82 131 85 (Pubitemid 34654217)
37. U Schaeppi IA Heyman RW Fleischman H Rosenkrantz V Ilievski R Phelan 1973 cis-dichlorodiammineplatinum(II) (NSC-119 875): Preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice Toxicol Appl Pharmacol. 25 230 41
38. KR Schmelzer L Kubala JW Newman IH Kim JP Eiserich BD Hammock 2005 Soluble epoxide hydrolase is a therapeutic target for acute inflammation Proc Natl Acad Sci U S A. 102 9772 7 (Pubitemid 40993644)
39. KR Schmelzer B Inceoglu L Kubala IH Kim SL Jinks JP Eiserich 2006 Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors Proc Natl Acad Sci U S A. 103 13646 51 (Pubitemid 44413961)
40. CJ Sinal M Miyata M Tohkin K Nagata JR Bend FJ Gonzalez 2000 Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation J Biol Chem. 275 40504 10 (Pubitemid 32064687)
41. KR Smith KE Pinkerton T Watanabe TL Pedersen SJ Ma BD Hammock 2005 Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor Proc Natl Acad Sci USA. 102 2186 91 (Pubitemid 40262033)
42. KL Thompson CA Afshari RP Amin TA Bertram B Car M Cunningham 2004 Identification of platform-independent gene expression markers of cisplatin nephrotoxicity Environ Health Perspect. 112 488 94 (Pubitemid 38404560)
43. DM Townsend M Deng L Zhang MG Lapus MH Hanigan 2003 Metabolism of cisplatin to a nephrotoxin in proximal tubule cells J Am Soc Nephrol. 14 1 10 (Pubitemid 36026291)
44. T Watanabe D Schulz C Morisseau BD Hammock 2006 High-throughput pharmacokinetic method: Cassette dosing in mice associated with minuscule serial bleedings and LC/MS/MS analysis Anal Chim Acta. 559 37 44 (Pubitemid 43184285)
45. JA Winston R Safirstein 1985 Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat Am J Physiol. 249 F490 6 (Pubitemid 16185880)
46. D Xu N Li Y He V Timofeyev L Lu HJ Tsai 2006 Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors Proc Natl Acad Sci U S A. 103 18733 38
47. C Yang V Kaushal RS Haun R Seth SV Shah GP Kaushal 2008 Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity Cell Death Differ 15 530 544
48. Z Yu F Xu LM Huse C Morisseau AJ Draper JW Newman 2000 Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids Circ Res. 87 992 8
49. RA Zager AC Johnson S Lund J Randolph-Habecker 2007 Toll-like receptor (TLR4) shedding and depletion: acute proximal tubular cell responses to hypoxic and toxic injury Am J Physiol Renal Physiol. 292 F304 12 (Pubitemid 46105270)
50. DC Zeldin J Kobayashi JR Falck BS Winder BD Hammock JR Snapper 1993 Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase J Biol Chem. 268 6402 7 (Pubitemid 23099336)